CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

/ 3
Filters:
Show search box
2012-05-14
Innovative Medicines Initiative – a public private partnership success story

Innovative Medicines Initiative – a public private partnership success story

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 31 national associations and 35 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 2,000 companies committed ... Read more
Tags bioforum , pharma
2012-05-07
Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medi

Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medicines company globally and in the US

Novartis has signed a definitive agreement to acquire specialty dermatology generics company Fougera Pharmaceuticals. Under the terms of the agreement, Novartis will acquire the business, which is based in Melville, New York, for USD 1.525 billion in an all-cash transaction.... Read more
Tags pharma
2012-04-26
AMGEN To Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company

AMGEN To Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company

Acquisition Will Build on Amgen’s Existing Business and Provide a Platform for Growth in Turkey and This Strategically Important Region... Read more
Tags pharma , turkey
2012-04-16
 Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Despite the dramatic growth in the number and power of molecular diagnostic technologies, the increasing clinical and economic value of the tests derived from them, and the therapeutic power of the drugs whose use can and should be guided by those tests, the reimbursement system for diagnostic tests ... Read more
Tags bioforum , medicine , pharma
2012-04-09 to 2012-04-12
 Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Lead investor Banexi Ventures Partners joins strong investment consortium... Read more
Tags medicine , pharma
Clinical Trials in Central and Eastern Europe become the global advantage

Clinical Trials in Central and Eastern Europe become the global advantage

Newly developed drugs must be controlled in terms of efficiency and safety. At this step clinical trials are inevitable. They account for the biggest and also the longest part of total cost connected with introduction of new pharmaceuticals to the market. It is estimated that the global market of cli... Read more
Tags medicine , pharma , interview , russia
2012-03-21 to 2012-03-22
Recent Trends in Pharma Partnering

Recent Trends in Pharma Partnering

With the current challenges facing the industry, large Pharma is increasingly looking to expand their pipelines with external science. As the academic and biotechnology sectors have become increasingly successful at bringing innovative compounds and R&D technologies forward, a strong interest in par... Read more
Tags bioforum , pharma
GSK and J&J launch €150m fund with Index Ventures

GSK and J&J launch €150m fund with Index Ventures

Index Ventures announced today the launch of its first fund solely dedicated to making investments in the life sciences sector. This €150m fund includes investments from several of Index’s largest existing limited partners and two companies, GlaxoSmithKline (GSK) and the venture capital affiliate of ... Read more
Tags pharma
2012-03-12 to 2012-03-13
Prix Galien - finally in Poland! World-class contest promoting innovative developments in p

Prix Galien - finally in Poland! World-class contest promoting innovative developments in pharmacy and medicine

In 2012, for the first time, Poland will be the host of the first edition of the prestigious Prix Galien international contest, which for more than 40 years has been rewarding the greatest breakthroughs in pharmacy and medicine. The award enjoys the highest recognition and is treated as the equivalen... Read more
Tags medicine , events , pharma
Treatment tailored to the patient – the world of personalized medicine

Treatment tailored to the patient – the world of personalized medicine

We are all alike – one could say when it comes to general features of people all around the world. Our general appearance, physical and psychological needs are very similar. Yet, “similar” does not mean “the same”. This fact is particularly important in terms of healthcare, where the issue of differe... Read more
Tags medicine , pharma
2012-03-06 to 2012-03-07
 InDex Pharmaceuticals Starts Phase III COLLECT Study with Kappaproct®

InDex Pharmaceuticals Starts Phase III COLLECT Study with Kappaproct®

InDex Pharmaceuticals yesterday announced the start of the COLLECT trial, a European multicenter Phase III study to evaluate the effectiveness and safety of Kappaproct for the treatment of chronic active ulcerative colitis (UC) patients not responding to available therapy. Kappaproct is a DNA-based i... Read more
Tags pharma
Biosimilars - Pioneering the future

Biosimilars - Pioneering the future

Several biological drugs will go off patent over the next years. In fact, biologics with estimated total sales value of USD 63 bn (approx. 40% of forecast market) are expected to lose patent protection by 2015 globally, rising to more than USD 100 bn by 2020. The EU has been leading the world in the... Read more
Tags bioforum , pharma
2012-02-27
 JCI Venture bets on the red biotechnology

JCI Venture bets on the red biotechnology

The investment portfolio of the JCI Venture fund added an innovative biotechnological company, simAb co. The co-partnership will be active in the biotechnological drugs sector, working on new therapies against tumor and metabolic conditions, which afflict millions of patients. The team of originators... Read more
Tags poland , pharma
2012-02-24
Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

On January 2012 the Innovation for Health contest was completed. Drug companies, patient associations, drugs, hospitals and foundations could have been rewarded in one of the following categories: prophylaxis, education and promotion of patient activity, management, medical technologies and equipment... Read more
Tags biotechnology , poland , pharma